Skip to main content
$2.08 $0.08 (4.0%)

04:00 PM EDT on 09/29/23

Rockwell Medical Tech (NASDAQ:RMTI)

CAPS Rating: 2 out of 5

The Company manufactures, sells and distributes hemodialysis concentrates and other ancillary medical products and supplies used in the treatment of patients with End Stage Renal Disease.

Current Price $2.08 Mkt Cap $59.3M
Open $2.05 P/E Ratio -2.37
Prev. Close $2.08 Div. (Yield) $0.00 (0.0%)
Daily Range $2.03 - $2.19 Volume 301,639
52-Wk Range $0.84 - $6.24 Avg. Daily Vol. 1,043,422

Caps

How do you think NASDAQ:RMTI will perform against the market?

Add Stock to CAPS Watchlist

All Players

87 Outperform
16 Underperform
 

All-Star Players

7 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RMTI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

lightrock (< 20)
Submitted September 22, 2019

There is not a button for "both" or "either" outperform or underperform. I think it will do one or the other, in that a big move is primed because I think it is tired sitting in the doldrums. Either past controversy is behind it, or the stragglers in… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Fools bullish on NASDAQ:RMTI are also bullish on:

Fools bearish on NASDAQ:RMTI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RMTI.

Recs

1
Member Avatar lightrock (< 20) Submitted: 9/21/2019 9:42:38 PM : Outperform Start Price: $3.25 NASDAQ:RMTI Score: -79.83

There is not a button for "both" or "either" outperform or underperform. I think it will do one or the other, in that a big move is primed because I think it is tired sitting in the doldrums. Either past controversy is behind it, or the stragglers in it will finally give up. There should be a button for this kind of opinion.

Recs

1
Member Avatar LifeScientist (< 20) Submitted: 3/2/2016 7:49:25 PM : Outperform Start Price: $6.11 NASDAQ:RMTI Score: -181.08

watch

Recs

1
Member Avatar jtmeltzer (< 20) Submitted: 7/13/2015 9:35:54 PM : Outperform Start Price: $18.00 NASDAQ:RMTI Score: -192.31

The company is the #2 provider of hemodialysis solutions in the US. They are currently going to launch the only FDA approved iron therapy to treat kidney failure patients. This may save the hemodialysis providers millions in savings as they will need to buy less Epogen. These providers get paid per hemodialysis session - so anyway to reduce expenditures is their only way to improve margins. This stock is about to breakthrough $18 resistance. Don't wait for a pullback.

Leaderboard

Find the members with the highest scoring picks in RMTI.

Score Leader

3004pawel

3004pawel (< 20) Score: +346.74

The Score Leader is the player with the highest score across all their picks in RMTI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
3004pawel < 20 1/21/2010 Underperform 3W $7.28 -71.50% +275.25% +346.74 0 Comment
shorttest4 35.28 3/8/2010 Underperform 5Y $6.28 -66.96% +274.13% +341.09 0 Comment
jroren 97.40 6/21/2010 Underperform 3M $4.58 -54.69% +277.90% +332.59 0 Comment
epsdecreases 22.59 10/31/2012 Underperform 5Y $7.40 -71.96% +201.36% +273.32 0 Comment
VeryShiny < 20 3/19/2013 Underperform 3M $3.69 -43.77% +177.51% +221.28 0 Comment
kevrose31 79.18 1/10/2014 Underperform 1Y $10.52 -80.28% +132.39% +212.66 0 Comment
donp8 < 20 5/19/2014 Underperform 3W $9.97 -79.19% +127.76% +206.95 1 Comment
icebit1 22.79 11/4/2014 Underperform 5Y $9.69 -78.58% +112.52% +191.09 0 Comment
JCLscapXperiment 91.24 12/15/2014 Underperform 5Y $8.33 -75.09% +111.64% +186.73 1 Comment
rothenbr 43.15 8/22/2016 Underperform 3Y $7.24 -71.34% +95.86% +167.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RMTI.